BC43 Inter-amer 30

     
BW20020924002549  20020924T203904Z UTC


( BW)(ELI-LILLY-&-CO)(BC43) Re Alliance

    Business Editors
    UK REGULATORY NEWS

    BEIJING--(BUSINESS WIRE)--Sept. 24, 2002--

               InnoCentive Builds on Rapidly Expanding
                    Scientific Community in China

                     Chairman Addresses Attendees
              About Market Opportunities and Challenges

InnoCentive(TM) today announced its participation at the 8th Annual
China Chemicals and Plastics Industry Conference in Beijing, 23 -24
September, 2002. The executive-level conference is an opportunity for
industry leaders to review and focus on business issues for
multi-international corporations. InnoCentive provides an online forum
that allows world-class scientists and innovation-driven companies to
collaborate in a global scientific community to solve difficult R&D
problems.

InnoCentive's chairman, Alpheus Bingham Ph.D, will be a featured
speaker at the conference on Tuesday, 24 September, where he will
deliver his presentation, titled `E-R&D and Opportunities in China.'
Bingham will address the opportunities and obstacles for the companies
both in China and in the West.

"China represents a very important opportunity for InnoCentive and the
chemical and pharmaceutical industries," said Bingham. "We are very
committed to recruiting world-class Chinese scientists to be
InnoCentive `solvers' who can provide the best possible solutions to
some of the most difficult challenges in the industry."

"As InnoCentive is introducing new disciplines, Chinese scientists
will be instrumental in addressing these challenges," said Ali
Hussein, vice president of marketing for InnoCentive. Earlier this
month, the company announced the expansion of its `challenge' base in
the areas of biology and biochemistry.

"China is an extremely important market for us due to its rich history
of scientific innovation," said Hussein. "China adds to InnoCentive's
truly diversified global, scientific community." InnoCentive has
recruited more than 12,000 solvers around the world in over 100
countries that work independently to solve intellectually challenging
R&D problems and earn financial awards for their solutions.

About InnoCentive

InnoCentive is the first online forum that allows world-class
scientists and science-based companies to collaborate in a global
scientific community to achieve innovative solutions to complex
challenges. InnoCentive is an e-business venture of Eli Lilly and
Company, a leading innovation-driven pharmaceutical company. To learn
more, visit the InnoCentive web site at www.innocentive.com.

   Short Name: Lilly (Eli) & Co
   Category Code: SAL
   Sequence Number: 00000832
   Time of Receipt (offset from UTC): 20020924T200336+0100

    --30--mj/in*

    CONTACT: InnoCentive, Inc., Andover, Mass.
             Lori Costa, 978/482-3306
             978/482-3300 main
             978/482-3400 fax

    KEYWORD: MASSACHUSETTS INDIANA CHINA INTERNATIONAL ASIA PACIFIC
    INDUSTRY KEYWORD: PHARMACEUTICAL MEDICAL CHEMICALS/PLASTICS
E-COMMERCE COMPUTERS/ELECTRONICS TRADESHOW
    SOURCE: Lilly (Eli) & Co

Today's News On The Net - Business Wire's full file on the Internet
                          with Hyperlinks to your home page.
                          URL: http://www.businesswire.com

Inter-amer 30 (LSE:BC43)
Historical Stock Chart
From Dec 2024 to Jan 2025

Inter-amer 30 (LSE:BC43)
Historical Stock Chart
From Jan 2024 to Jan 2025